Overview


According to FutureWise analysis the market for stromal vascular fraction in 2023 is US$ 93.17 million, and is expected to reach US$ 128.69 million by 2031 at a CAGR of 4.10%.

Stromal vascular fraction is crucial in regenerative medicine and in treating various chronic disorders. Multiple clinical and pre-clinical investigations have been undertaken for establishing the function of stromal vascular fraction for treating osteoarthritis, rheumatoid arthritis, cartilage regeneration, etc. This method has huge potential in treating orthopaedics due to their homeostatic and immune-modulation properties. Furthermore, the regenerative abilities of SVT are derivations of soluble factors having multiple differentiating abilities with huge potential. Moreover, the SVF injections are intrusive and non-surgical option in orthopaedics for treating musculoskeletal diseases. Such factors shall positively impact the stromal vascular fraction market growth.

  • IntelliCell BioSciences Inc.
  • Cytori Therapeutics Inc.
  • Cellular Biomedicine Group Inc.
  • InGeneron Inc.
  • Lifecell Corporation (Allergen PLC)
  • GE Healthcare (Biosafe Group SA)
  • Tissue Genesis Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products

By Application

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/ Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into product, application, end user and region. The product segment is classified into SVF aspiration products, SCF transfer products, SVF isolation products. The SVF isolation products segment is further divided into enzymatic isolation products, non-enzymatic isolation products, automated POC devices. The application segment is fragmented into cosmetic applications, orthopedic applications, soft tissue applications and others. The end user segment is diversified into hospitals, specialty clinics, stem cell banks and others.

The North America region is expected to hold the largest stromal vascular fraction market share owing to the rising prevalence of musculoskeletal disorders like osteoarthritis, growing awareness pertaining to stem cell therapy, soaring number of cosmetic surgeries along with growing insistence from clinicians. Furthermore, the increasing investments in research and development of novel technologies coupled with the escalating number of private hospitals across the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global stromal vascular fraction market By Product, By Application, By Field End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Stromal Vascular Fraction Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview

    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ultrasound Gel Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Stromal Vascular Fraction Market Analysis tools

    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Stromal Vascular Fraction Market, By Product Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. High Field Stromal Vascular Fraction
        2. Low to Mid Field Stromal Vascular Fraction
        3. Very High Field Stromal Vascular Fraction

  • 8.   Stromal Vascular Fraction Market, By Application Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Cosmetic Applications
        2. Orthopedic Applications
        3. Soft Tissue Applications
        4. Others

  • 9.   Stromal Vascular Fraction Market, By End User Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Hospitals
        2. Specialty Clinics
        3. Stem Cell Banks/ Laboratories
        4. Others

  • 10.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4 . Rest of North America
        3. Market Size (USD Mn) Forecast for North America 2023-2031

  • 11.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Uruguay
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Mn) Forecast for Latin America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Mn) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Mn) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. UAE
         2.2. South Africa
         2.3. Egypt
         2.4. Saudi Arabia
         2.5. Rest of MEA
        3. Market Size (US$ Mn) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. IntelliCell BioSciences Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cytori Therapeutics Inc.
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cellular Biomedicine Group Inc.
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. InGeneron Inc.
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Lifecell Corporation (Allergen PLC)
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. GE Healthcare (Biosafe Group SA)
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tissue Genesis Inc.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  Competitive Intelligence and Competitive Matrix

    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 19.  Major Deals and Strategic Alliances Analysis

    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies

  • 20.  Relevant Case Studies and Latest News Updates

    •     

  • 21.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11